Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Diabetes/Metabolism Research and Reviews
|
December 29, 2016
Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetes
D R Webb, F Zaccardi, M J Davies, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 18, 2011
Screening for type 2 diabetes. Lessons from the ADDITION-Europe study
M van den Donk, A Sandbaek, K Borch-Johnsen, et al.
International Journal of Obesity (2005)
|
February 22, 2012
The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes
G Andersen, L T Dalgaard, J M Justesen, et al.
Diabetes/Metabolism Research and Reviews
|
November 25, 2017
Early-onset type 2 diabetes: Age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes-Results from the DD2 study
A Bo, R W Thomsen, J S Nielsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 19, 2014
Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial
J A Black, S J Sharp, N J Wareham, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 10, 2015
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial
L Tao, E C F Wilson, N J Wareham, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 25, 2012
Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial
R K Simmons, S J Sharp, A Sandbæk, et al.
Diabetologia
|
November 17, 2007
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes
T Sparsø, G Andersen, T Nielsen, et al.
Diabetologia
|
August 9, 2011
Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1
S S Torekov, L Ma, N Grarup, et al.
Diabetologia
|
September 30, 2010
A role for coding functional variants in HNF4A in type 2 diabetes susceptibility
B Jafar-Mohammadi, C J Groves, A P Gjesing, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Diabetes/Metabolism Research and Reviews
|
December 29, 2016
Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetes
D R Webb, F Zaccardi, M J Davies, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
June 18, 2011
Screening for type 2 diabetes. Lessons from the ADDITION-Europe study
M van den Donk, A Sandbaek, K Borch-Johnsen, et al.
International Journal of Obesity (2005)
|
February 22, 2012
The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes
G Andersen, L T Dalgaard, J M Justesen, et al.
Diabetes/Metabolism Research and Reviews
|
November 25, 2017
Early-onset type 2 diabetes: Age gradient in clinical and behavioural risk factors in 5115 persons with newly diagnosed type 2 diabetes-Results from the DD2 study
A Bo, R W Thomsen, J S Nielsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 19, 2014
Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial
J A Black, S J Sharp, N J Wareham, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 10, 2015
Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial
L Tao, E C F Wilson, N J Wareham, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
July 25, 2012
Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial
R K Simmons, S J Sharp, A Sandbæk, et al.
Diabetologia
|
November 17, 2007
The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes
T Sparsø, G Andersen, T Nielsen, et al.
Diabetologia
|
August 9, 2011
Homozygous carriers of the G allele of rs4664447 of the glucagon gene (GCG) are characterised by decreased fasting and stimulated levels of insulin, glucagon and glucagon-like peptide (GLP)-1
S S Torekov, L Ma, N Grarup, et al.
Diabetologia
|
September 30, 2010
A role for coding functional variants in HNF4A in type 2 diabetes susceptibility
B Jafar-Mohammadi, C J Groves, A P Gjesing, et al.
Page
of 14